Ahren Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about February 4, 2022
February 01 2022 - 5:10PM
Ahren Acquisition Corp. (Nasdaq: AHRNU) (the “Company”) announced
that holders of the units sold in the Company’s initial public
offering of 29,999,800 units completed on December 17, 2021,
including 2,499,800 units sold in connection with the exercise of
the over-allotment option in part (the “Offering”) may elect to
separately trade the Class A ordinary shares and warrants included
in the units commencing on or about February 4, 2022. Any units not
separated will continue to trade on The Nasdaq Global Market under
the symbol “AHRNU”, and each of the Class A ordinary shares and
warrants will separately trade on The Nasdaq Global Market under
the symbols “AHRN” and “AHRNW,” respectively. No fractional
warrants will be issued upon separation of the units and only whole
warrants will trade. Holders of units will need to have their
brokers contact Continental Stock Transfer & Trust Company, the
Company’s transfer agent, in order to separate the units into Class
A ordinary shares and warrants.
Ahren Acquisition Corp. is a blank check company whose business
purpose is to effect a merger, capital share exchange, asset
acquisition, share purchase, reorganization or similar business
combination with one or more businesses. The Company’s efforts to
identify a prospective initial business combination target will
initially be focused on high growth, domain leading companies
fueled by breakthrough deep technology and/or deep science. The
Company believes that it is well positioned to pursue initial
business combination opportunities within its four domains of
interest: Planet & Efficient Energy; Brain & Artificial
Intelligence; Genetics & Platform Technologies; and Space,
Robotics & Physics.
The Company’s sponsor is AACS LP, which is an affiliate of Ahren
LP (“Ahren”). Ahren is an investment fund that seeks to make
transformative investments in companies that have the capacity to
penetrate large markets within and among the Company’s four domains
of interest and on a global stage. Ahren was founded in 2017 by
technology and disruptive healthcare investor and Founding &
General Partner Alice Newcombe-Ellis, alongside co-founding Science
Partners that have founded companies and/or whose inventions and
technologies are today valued in excess of $100 billion combined.
Alice Newcombe-Ellis acts as the Company’s Chief Executive
Officer.
Registration statements relating to the securities were declared
effective on December 14, 2021 in accordance with Section 8(a) of
the Securities Act of 1933, as amended. This press release shall
not constitute an offer to sell or the solicitation of an offer to
buy, nor shall there be any sale of these securities in any state
or jurisdiction in which such offer, solicitation, or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
Cautionary Note Concerning Forward-Looking
Statements
This press release contains statements that constitute
“forward-looking statements,” including with respect to the
Company’s search for an initial business combination.
Forward-looking statements are subject to numerous conditions, many
of which are beyond the control of the Company, including those set
forth in the Risk Factors section of the Company’s registration
statement for the initial public offering filed with the SEC.
Copies are available on the SEC’s website, www.sec.gov. The Company
undertakes no obligation to update these statements for revisions
or changes after the date of this release, except as required by
law.
# # # CONTACT: Investor Relations, Ahren
Acquisition Corp. info@ahrenacq.com
Ahren Acquisition (NASDAQ:AHRNU)
Historical Stock Chart
From Sep 2024 to Oct 2024
Ahren Acquisition (NASDAQ:AHRNU)
Historical Stock Chart
From Oct 2023 to Oct 2024